Soni Medicare Limited (BOM:539378)
India · Delayed Price · Currency is INR 69.35
-3.64 (-4.99%)
At close: Aug 24, 2026
Soni Medicare Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 219.84 | 247.08 | 298.38 | 272.55 | 275.32 | 226 |
Other Revenue | 15.48 | 11.5 | 9.5 | 7.5 | 7.5 | 4.2 |
| 235.32 | 258.58 | 307.88 | 280.05 | 282.82 | 230.2 | |
Revenue Growth | -25.05% | -16.01% | 9.94% | -0.98% | 22.86% | 44.14% |
Cost of Revenue | 133.96 | 151.89 | 165.65 | 155.26 | 147.87 | 129.14 |
Gross Profit | 101.36 | 106.69 | 142.23 | 124.79 | 134.95 | 101.06 |
Selling, General & Admin | - | 1.77 | 3.81 | 6.68 | 6.63 | 3.64 |
Other Operating Expenses | 117.97 | 117.9 | 129.73 | 125.8 | 122.93 | 91.58 |
Operating Expenses | 123.13 | 124.82 | 138.56 | 137.72 | 136.11 | 102.98 |
Operating Income | -21.78 | -18.12 | 3.68 | -12.92 | -1.16 | -1.92 |
Interest Expense | -13.57 | -11.9 | -9.34 | -8.36 | -6.76 | -5.79 |
Interest & Investment Income | - | 1.39 | 1.13 | 1.19 | 1.14 | 0.92 |
Other Non Operating Income (Expenses) | - | 2.01 | 2.32 | 3.82 | 0.68 | -0.01 |
EBT Excluding Unusual Items | -35.35 | -26.63 | -2.22 | -16.28 | -6.11 | -6.81 |
Gain (Loss) on Sale of Investments | - | 0.07 | - | - | - | - |
Gain (Loss) on Sale of Assets | - | 0.15 | - | - | - | 0.12 |
Pretax Income | -35.35 | -26.41 | -2.22 | -16.28 | -6.11 | -6.68 |
Income Tax Expense | 0.81 | 0.67 | -0.35 | 0.54 | 0.62 | -0.68 |
Net Income | -36.16 | -27.08 | -1.86 | -16.82 | -6.73 | -6.01 |
Net Income to Common | -36.16 | -27.08 | -1.86 | -16.82 | -6.73 | -6.01 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 5 | 4 | 4 | 4 | 4 | 4 |
Shares Outstanding (Diluted) | 5 | 4 | 4 | 4 | 4 | 4 |
Shares Change | 80.63% | - | - | - | - | - |
EPS (Basic) | -7.94 | -6.35 | -0.44 | -3.94 | -1.58 | -1.41 |
EPS (Diluted) | -7.94 | -6.35 | -0.44 | -3.94 | -1.58 | -1.41 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | - | -5.93 | 8.76 | 1.23 | -1.85 | -32.43 |
Free Cash Flow Per Share | - | -1.39 | 2.05 | 0.29 | -0.43 | -7.60 |
Gross Margin | 43.07% | 41.26% | 46.20% | 44.56% | 47.72% | 43.90% |
Operating Margin | -9.25% | -7.01% | 1.19% | -4.61% | -0.41% | -0.84% |
Profit Margin | -15.36% | -10.47% | -0.60% | -6.01% | -2.38% | -2.61% |
Free Cash Flow Margin | - | -2.29% | 2.84% | 0.44% | -0.66% | -14.09% |
EBITDA | -16.6 | -12.98 | 8.7 | -7.69 | 5.39 | 5.83 |
EBITDA Margin | -7.05% | -5.02% | 2.83% | -2.74% | 1.91% | 2.53% |
D&A For EBITDA | 5.18 | 5.15 | 5.02 | 5.24 | 6.55 | 7.76 |
EBIT | -21.78 | -18.12 | 3.68 | -12.92 | -1.16 | -1.92 |
EBIT Margin | -9.25% | -7.01% | 1.19% | -4.61% | -0.41% | -0.84% |
Revenue as Reported | 235.32 | 262.45 | 311.84 | 285.24 | 284.96 | 232.68 |
Advertising Expenses | - | 1.77 | 3.81 | 6.68 | 6.63 | 3.64 |